VANDA PHARMACEUTICALS INC's ticker is VNDA and the CUSIP is 921659108. A total of 166 filers reported holding VANDA PHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is 2.80 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,722,249 | -61.4% | 630,150 | -41.0% | 0.00% | -50.0% |
| Q2 2023 | $7,044,418 | +4.7% | 1,068,956 | +7.9% | 0.00% | 0.0% |
| Q1 2023 | $6,729,197 | +8.2% | 991,045 | +17.7% | 0.00% | 0.0% |
| Q4 2022 | $6,221,000 | -31.0% | 842,151 | -7.7% | 0.00% | -33.3% |
| Q3 2022 | $9,015,000 | +5.7% | 912,323 | +16.6% | 0.00% | 0.0% |
| Q2 2022 | $8,527,000 | -5.6% | 782,425 | -2.0% | 0.00% | 0.0% |
| Q1 2022 | $9,033,000 | -24.2% | 798,754 | +5.2% | 0.00% | 0.0% |
| Q4 2021 | $11,915,000 | +84.6% | 759,281 | +101.6% | 0.00% | +50.0% |
| Q3 2021 | $6,454,000 | -18.5% | 376,613 | +2.3% | 0.00% | 0.0% |
| Q2 2021 | $7,919,000 | +56.8% | 368,197 | +9.5% | 0.00% | 0.0% |
| Q1 2021 | $5,051,000 | -2.3% | 336,307 | -14.5% | 0.00% | 0.0% |
| Q4 2020 | $5,168,000 | +16.3% | 393,306 | -14.5% | 0.00% | 0.0% |
| Q3 2020 | $4,444,000 | +5.7% | 459,988 | +25.2% | 0.00% | 0.0% |
| Q2 2020 | $4,204,000 | +9.1% | 367,418 | -1.3% | 0.00% | 0.0% |
| Q1 2020 | $3,855,000 | -33.8% | 372,102 | +4.8% | 0.00% | 0.0% |
| Q4 2019 | $5,826,000 | +21.9% | 355,032 | -1.3% | 0.00% | 0.0% |
| Q3 2019 | $4,779,000 | -11.6% | 359,836 | -6.2% | 0.00% | 0.0% |
| Q2 2019 | $5,404,000 | -35.3% | 383,491 | -15.5% | 0.00% | -50.0% |
| Q1 2019 | $8,347,000 | -49.1% | 453,568 | -27.7% | 0.00% | -50.0% |
| Q4 2018 | $16,398,000 | +254.5% | 627,599 | +211.4% | 0.01% | +300.0% |
| Q3 2018 | $4,626,000 | +125.4% | 201,561 | +87.1% | 0.00% | +100.0% |
| Q2 2018 | $2,052,000 | +23.8% | 107,726 | +9.5% | 0.00% | 0.0% |
| Q1 2018 | $1,657,000 | +24.3% | 98,385 | +12.3% | 0.00% | 0.0% |
| Q4 2017 | $1,333,000 | -15.5% | 87,646 | -0.6% | 0.00% | 0.0% |
| Q3 2017 | $1,578,000 | +9.5% | 88,160 | -0.3% | 0.00% | 0.0% |
| Q2 2017 | $1,441,000 | -25.0% | 88,436 | -34.1% | 0.00% | 0.0% |
| Q4 2014 | $1,922,000 | +205.1% | 134,194 | +121.3% | 0.00% | – |
| Q3 2014 | $630,000 | +10400.0% | 60,645 | +17227.1% | 0.00% | – |
| Q2 2014 | $6,000 | -92.8% | 350 | -93.2% | 0.00% | – |
| Q1 2014 | $83,000 | -82.5% | 5,130 | -86.6% | 0.00% | – |
| Q4 2013 | $474,000 | -51.3% | 38,230 | -56.9% | 0.00% | -100.0% |
| Q3 2013 | $974,000 | +5629.4% | 88,745 | +3939.4% | 0.00% | – |
| Q2 2013 | $17,000 | – | 2,197 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Profit Investment Management, LLC | 326,997 | $1,412,627 | 1.00% |
| Stonepine Capital Management, LLC | 477,903 | $2,064,541 | 0.69% |
| Krensavage Asset Management, LLC | 360,429 | $1,557 | 0.57% |
| Nantahala Capital Management | 1,000,000 | $4,320,000 | 0.37% |
| Monaco Asset Management SAM | 135,000 | $583,200 | 0.17% |
| CTC Alternative Strategies, Ltd. | 18,400 | $79,488 | 0.15% |
| GSA CAPITAL PARTNERS LLP | 406,019 | $1,754 | 0.15% |
| Sio Capital Management, LLC | 97,616 | $421,701 | 0.13% |
| HUSSMAN STRATEGIC ADVISORS, INC. | 156,000 | $673,920 | 0.13% |
| Virtus ETF Advisers LLC | 48,530 | $209,650 | 0.13% |